Back
Aclaris Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60
ACRS
Aclaris Therapeutics
Last Price:
3.87
Seasonality Move:
46.43%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACRS is experiencing slight buying pressure.
Aclaris Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.15 | Buy |
| 20-day SMA: | 2.52 | Buy |
| 50-day SMA: | 1.72 | Buy |
| 200-day SMA: | 1.34 | Buy |
| 8-day EMA: | 3.42 | Buy |
| 20-day EMA: | 2.69 | Buy |
| 50-day EMA: | 2.01 | Buy |
| 200-day EMA: | 2.02 | Buy |
Aclaris Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.63 | Buy |
| Relative Strength Index (14 RSI): | 74.71 | Buy |
| Chaikin Money Flow: | 121913 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.35 - 3.17) | Buy |
| Bollinger Bands (100): | (0.84 - 2.12) | Buy |
Aclaris Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aclaris Therapeutics Stock
Is Aclaris Therapeutics Stock a Buy?
- Aclaris Therapeutics share price is 4.32 while ACRS 8-day simple moving average is 3.15, which is a Buy signal.
- The stock price of ACRS is 4.32 while Aclaris Therapeutics 20-day SMA is 2.52, which makes it a Buy.
- Aclaris Therapeutics 50-day simple moving average is 1.72 while ACRS share price is 4.32, making it a Buy technically.
- ACRS stock price is 4.32 and Aclaris Therapeutics 200-day simple moving average is 1.34, creating a Buy signal.
ACRS Technical Analysis vs Fundamental Analysis
Buy
60
Aclaris Therapeutics (ACRS)
is a Buy
Is Aclaris Therapeutics a Buy or a Sell?
-
Aclaris Therapeutics stock is rated a Buy
The current Aclaris Therapeutics [ACRS] share price is $4.32. The Score for ACRS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Aclaris Therapeutics Stock Info
Market Cap:
308.58M
Price in USD:
4.32
Share Volume:
2.93M
Aclaris Therapeutics 52-Week Range
52-Week High:
5.17
52-Week Low:
0.77
Buy
60
Aclaris Therapeutics (ACRS)
is a Buy
Aclaris Therapeutics Share Price Forecast
-
What is the Aclaris Therapeutics stock price today?
The Aclaris Therapeutics stock price is 4.32 USD today. -
Will ACRS stock go up or go down?
Aclaris Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aclaris Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aclaris Therapeutics is not overvalued.
Is Aclaris Therapeutics Stock a Buy?
- Aclaris Therapeutics share price is 4.32 while ACRS 8-day exponential moving average is 3.42, which is a Buy signal.
- The stock price of ACRS is 4.32 while Aclaris Therapeutics 20-day EMA is 2.69, which makes it a Buy.
- Aclaris Therapeutics 50-day exponential moving average is 2.01 while ACRS share price is 4.32, making it a Buy technically.
- ACRS stock price is 4.32 and Aclaris Therapeutics 200-day simple moving average is 2.02, creating a Buy signal.
Fundamental Analysis of Aclaris Therapeutics
Is Aclaris Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.90 per share, and an increase next year of $0.22 per share.
Technical Analysis of Aclaris Therapeutics
Should I short Aclaris Therapeutics stock?
- ACRS Moving Average Covergence Divergence (MACD) indicator is 0.63, suggesting Aclaris Therapeutics is a Buy
- Aclaris Therapeutics Relative Strength Index (RSI) is 74.71, which suggest Aclaris Therapeutics is overbought
- The Bollinger Bands (25) for Aclaris Therapeutics is (1.35 - 3.17), which suggest Aclaris Therapeutics is a Buy
- The Bollinger Bands (100) for Aclaris Therapeutics is (0.84 - 2.12), which suggest Aclaris Therapeutics is a Buy
* Aclaris Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.